Photodynamic targeting of EGFR does not predict the treatment outcome in combination with the EGFR tyrosine kinase inhibitor Tyrphostin AG1478

Photochemical and Photobiological Sciences

Volumn 7, Issue 9, 2008, Pages 1032-1040

  Weyergang, Anette ^a   Kaalhus, Olav ^a   Berg, Kristian ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; EPIDERMAL GROWTH FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL LINE; CELL MEMBRANE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYSOSOME; NONHUMAN; PHOTOCHEMISTRY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SENSITIVITY ANALYSIS; TREATMENT OUTCOME;

EID: 50649120411     PISSN: 1474905X     EISSN: 14749092     Source Type: Journal    
DOI: 10.1039/b806209a     Document Type: Article

References (46)

1. D. E. Dolmans D. Fukumura R. K. Jain Photodynamic therapy for cancer Nat. Rev. Cancer 2003 3 380 387
2. T. J. Dougherty C. J. Gomer B. W. Henderson G. Jori D. Kessel M. Korbelik J. Moan Q. Peng Photodynamic therapy J. Natl. Cancer Inst. 1998 90 889 905
3. E. Buytaert M. Dewaele P. Agostinis Molecular effectors of multiple cell death pathways initiated by photodynamic therapy Biochim. Biophys. Acta 2007 1776 86 107
4. J. Moan K. Berg The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen Photochem. Photobiol. 1991 53 549 553
5. R. J. Pacifico K. K. Wang L. M. Wongkeesong N. S. Buttar L. S. Lutzke Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus Clin. Gastroenterol. Hepatol. 2003 1 252 257
6. P. Baas L. Murrer F. A. Zoetmulder F. A. Stewart H. B. Ris Z. N. van J. L. Peterse E. J. Rutgers Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies Br. J. Cancer 1997 76 819 826
7. M. S. Kavuru A. C. Mehta I. Eliachar Effect of photodynamic therapy and external beam radiation therapy on juvenile laryngotracheobronchial papillomatosis Am. Rev. Respir. Dis. 1990 141 509 510
8. D. J. Gilbert Treatment of actinic keratoses with sequential combination of 5-fluorouracil and photodynamic therapy J. Drugs Dermatol. 2005 4 161 163
9. M. G. del Carmen I. Rizvi Y. Chang A. C. Moor E. Oliva M. Sherwood B. Pogue T. Hasan Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo J. Natl. Cancer Inst. 2005 97 1516 1524
10. A. Zimmermann H. Walt U. Haller P. Baas S. D. Klein Effects of chlorin-mediated photodynamic therapy combined with fluoropyrimidines in vitro and in a patient Cancer Chemother. Pharmacol. 2003 51 147 154
11. A. K. Sinha S. Anand B. J. Ortel Y. Chang Z. Mai T. Hasan E. V. Maytin Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells Br. J. Cancer 2006 95 485 495
12. V. Kirveliene G. Grazeliene D. Dabkeviciene I. Micke D. Kirvelis B. Juodka J. Didziapetriene Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo Cancer Chemother. Pharmacol. 2006 57 65 72
13. A. Ferrario A. M. Fisher N. Rucker C. J. Gomer Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors Cancer Res. 2005 65 9473 9478
14. W. Liu M. R. Baer M. J. Bowman P. Pera X. Zheng J. Morgan R. A. Pandey A. R. Oseroff The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2 Clin. Cancer Res. 2007 13 2463 2470
15. A. Ferrario C. J. Gomer Avastin enhances photodynamic therapy treatment of Kaposi's sarcoma in a mouse tumor model J. Environ. Pathol. Toxicol. Oncol. 2006 25 251 259
16. F. Ciardiello G. Tortora EGFR antagonists in cancer treatment New Engl. J. Med. 2008 358 1160 1174
17. E. K. Rowinsky The erbB family: targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors Annu. Rev. Med. 2004 55 433 457
18. A. Wells EGF receptor Int. J. Biochem. Cell Biol. 1999 31 637 643
19. F. A. Al-Obeidi K. S. Lam Development of inhibitors for protein tyrosine kinases Oncogene 2000 19 5690 5701
20. Y. Zhou M. G. Brattain Synergy of epidermal growth factor receptor kinase inhibitor AG1478 and ErbB2 kinase inhibitor AG879 in human colon carcinoma cells is associated with induction of apoptosis Cancer Res. 2005 65 5848 5856
21. Y. Han C. G. Caday A. Nanda W. K. Cavenee H. J. Huang Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors Cancer Res. 1996 56 3859 3861
22. W. A. Denny Irreversible inhibitors of the erbB family of protein tyrosine kinases Pharmacol. Ther. 2002 93 253 261
23. A. Weyergang P. K. Selbo K. Berg Photochemically stimulated drug delivery increases the cytotoxicity and specificity of EGF-saporin J. Controlled Release 2006 111 165 173
24. A. Weyergang P. K. Selbo K. Berg Y1068 phosphorylation is the most sensitive target of disulfonated tetraphenylporphyrin-based photodynamic therapy on epidermal growth factor receptor Biochem. Pharmacol. 2007 74 226 235
25. K. Berg A. Western J. C. Bommer J. Moan Intracellular localization of sulfonated meso-tetraphenylporphines in a human carcinoma cell line Photochem. Photobiol. 1990 52 481 487
26. R. Soffietti R. Ruda E. Trevisan New chemotherapy options for the treatment of malignant gliomas Anticancer Drugs 2007 18 621 632
27. M. Zhang Z. Zhang C. K. Goldman J. Janik T. A. Waldmann Combination therapy for adult T-cell leukemia-xenografted mice: flavopiridol and anti-CD25 monoclonal antibody Blood 2005 105 1231 1236
28. C. H. Yun T. J. Boggon Y. Li M. S. Woo H. Greulich M. Meyerson M. J. Eck Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity Cancer Cell 2007 11 217 227
29. P. Matar F. Rojo R. Cassia G. Moreno-Bueno C. S. Di J. Tabernero M. Guzman S. Rodriguez J. Arribas J. Palacios J. Baselga Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting Clin. Cancer Res. 2004 10 6487 6501
30. H. K. Gan F. Walker A. W. Burgess A. Rigopoulos A. M. Scott T. G. Johns The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor AG1478 increases the formation of inactive untethered EGFR dimers. Implications for combination therapy with monoclonal antibody 806 J. Biol. Chem. 2007 282 2840 2850
31. G. Partik K. Hochegger M. Schorkhuber B. Marian Inhibition of epidermal-growth-factor-receptor-dependent signalling by tyrphostins A25 and AG1478 blocks growth and induces apoptosis in colorectal tumor cells in vitro J. Cancer Res. Clin. Oncol. 1999 125 379 388
32. T. G. Johns R. B. Luwor C. Murone F. Walker J. Weinstock A. A. Vitali R. M. Perera A. A. Jungbluth E. Stockert L. J. Old E. C. Nice A. W. Burgess A. M. Scott Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478 Proc. Natl. Acad. Sci. USA 2003 100 15871 15876
33. R. Mandic C. J. Rodgarkia-Dara L. Zhu B. J. Folz M. Bette E. Weihe A. Neubauer J. A. Werner Treatment of HNSCC cell lines with the EGFR-specific inhibitor cetuximab (Erbitux) results in paradox phosphorylation of tyrosine 1173 in the receptor FEBS Lett. 2006 580 4793 4800
34. A. P. Castano N. Tatiana M. R. Hamblin Mechanisms in photodynamic therapy: part one - photosensitizers, photochemistry and cellular localization Photodiagn. Photodyn. Ther. 2004 1 279 293
35. W. L. Yip A. Weyergang K. Berg H. H. Tonnesen P. K. Selbo Targeted delivery and enhanced cytotoxicity of cetuximab-saporin by photochemical internalization in EGFR-positive cancer cells Mol. Pharm. 2007 4 241 251
36. A. Bonsted B. O. Engesaeter A. Hogset G. M. Maelandsmo L. Prasmickaite C. D'Oliveira W. E. Hennink J. H. van Steenis K. Berg Photochemically enhanced transduction of polymer-complexed adenovirus targeted to the epidermal growth factor receptor J. Gene Med. 2006 8 286 297
37. N. Ahmad K. Kalka H. Mukhtar In vitro and in vivo inhibition of epidermal growth factor receptor-tyrosine kinase pathway by photodynamic therapy Oncogene 2001 20 2314 2317
38. S. M. Schieke C. von Montfort D. P. Buchczyk A. Timmer S. Grether-Beck J. Krutmann N. J. Holbrook L. O. Klotz Singlet oxygen-induced attenuation of growth factor signaling: possible role of ceramides Free Radical Res. 2004 38 729 737
39. P. de Witte P. Agostinis J. Van Lint W. Merlevede J. R. Vandenheede Inhibition of epidermal growth factor receptor tyrosine kinase activity by hypericin Biochem. Pharmacol. 1993 46 1929 1936
40. A. Weyergang O. Kaalhus K. Berg Photodynamic therapy with an endocytically located photosensitizer cause a rapid activation of the mitogen-activated protein kinases extracellular signal-regulated kinase, p38, and c-Jun NH2 terminal kinase with opposing effects on cell survival Mol. Cancer Ther. 2008 7 1740 1750
41. W. Liu A. R. Oseroff H. Baumann Photodynamic therapy causes cross-linking of signal transducer and activator of transcription proteins and attenuation of interleukin-6 cytokine responsiveness in epithelial cells Cancer Res. 2004 64 6579 6587
42. T. H. Yang C. T. Chen C. P. Wang P. J. Lou Photodynamic therapy suppresses the migration and invasion of head and neck cancer cells in vitro Oral Oncol. 2007 43 358 365
43. S. Zhuang G. D. Ouedraogo I. E. Kochevar Downregulation of epidermal growth factor receptor signaling by singlet oxygen through activation of caspase-3 and protein phosphatases Oncogene 2003 22 4413 4424
44. J. L. Fischel P. Formento G. Milano Epidermal growth factor receptor double targeting by a tyrosine kinase inhibitor (Iressa) and a monoclonal antibody (Cetuximab). Impact on cell growth and molecular factors Br. J. Cancer 2005 92 1063 1068
45. J. Amann S. Kalyankrishna P. P. Massion J. E. Ohm L. Girard H. Shigematsu M. Peyton D. Juroske Y. Huang S. J. Stuart Y. H. Kim J. R. Pollack K. Yanagisawa A. Gazdar J. D. Minna J. M. Kurie D. P. Carbone Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer Cancer Res. 2005 65 226 235
46. A. P. Castano P. Mroz M. R. Hamblin Photodynamic therapy and anti-tumour immunity Nat. Rev. Cancer 2006 6 535 545